How BPC-157 Works — Proposed Mechanisms
How does BPC-157 work? The proposed mechanisms from animal studies: nitric oxide, growth factor pathways and angiogenesis.
What is the working mechanism of BPC-157? The honest response is that the complete story is still unclear. It is true that we have observations from animal studies that indicate various proposed mechanisms. None of these mechanisms has been observed in clinical trials on humans, and the interactions of the mechanisms are still being studied. According to the studies done so far, some more is explained in the literature.
Why Mechanism Matters for a Research Peptide
From Observation to Pathway
Spread of BPC-157 studies concentrated on noting the results achieved - a tendon of a rat healed faster or a gastric ulcer healed more quickly. These observations gave rise to the second phase of studies aimed at explaining what caused these effects. It is essential to learn how a compound works, as this will help to understand whether its effect will be valid for other species, or other conditions or the effect of the studied compound is limited to a specific model. When it comes to BPC-157, several possible mechanisms of action have been suggested to explain its effects.
Proposed Mechanisms in Animal Models
Nitric Oxide System
Some researchers show evidence that BPC-157 impacts the nitric oxide (NO) system. In experiments performed on rats, when BPC-157 was administered, the subsequent release of NO, a substance associated with blood vessel enlargement, inflammation management and tissue regeneration, was shown to be affected. It was indicated that when NO pathways are blocked, this drastically reduces the influence of BPC-157 (Sikiric et al., 2006). So it can be inferred that NO is only one of the ways how BPC-157 can work.
Growth Factor Pathways (VEGF, EGF)
Vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF) are proteins involved in tissue repair and blood vessel formation. Research done on animals with BPC-157 treatment revealed a higher amount of these growth factors found in the areas of injury in rats (Chang et al., 2014). It should be mentioned that BPC-157 treatment is not the only method of affecting growth factors in rodent experiments. Its specific effect as well as its strength regarding other treatments is unknown.
Angiogenesis and Blood Vessel Formation
In relation to the data on the growth factor, several studies indicate that BPC-157 induced angiogenesis in animal wound models. The process of angiogenesis could be instrumental in tissue regeneration since the new blood supply is necessary for any healing process to take place. The above findings stem from the histological analysis of tissues of rats treated with BPC-157 (Brcic et al., 2009).
The FAK-Paxillin Pathway
Focal adhesion kinase (FAK) and paxillin are proteins essential for cell adhesion and movement, which play an important role in the healing of wounds. A study from 2011 with rats showed that BPC-157 activated the FAK-paxillin cascade in tendon fibroblasts, which contributed to the successful healing of tendons in the same study (Chang et al., 2011). This is one of the few known mechanisms of action of BPC-157.
How Studies Are Designed
Common Animal Models Used
The majority of research on BPC-157 uses either the Wistar or Sprague-Dawley rats though a few studies are conducted using mice. Fewer studies are conducted using rabbits in tendon studies. The selection of a suitable model determines what conclusions can be derived. The gastrointestinal physiology of rats, which is similar to that of humans, makes studies involving the rat stomach more applicable than studies involving the rat tendon.
Routes and Observations
BPC-157 has been delivered to subjects through multiple routes of administration, such as subcutaneous injection, intraperitoneal injection, and oral administration. The administration method is important because the bioavailability of each method is not the same. The oral trials are significant because peptides break down inside of the digestive system and BPC-157's apparent stability in stomach acid is part of the reason it is unique in peptide research.
| Model Type | Route | What Was Measured | Species |
|---|---|---|---|
| Gastric ulcer | Oral, IP injection | Ulcer size, mucosal integrity | Rat |
| Tendon transection | Local injection, IP | Healing rate, biomechanics | Rat, rabbit |
| Bone fracture | IP injection | Callus formation, bone density | Rat |
| Vascular injury | IP injection | Vessel patency, NO levels | Rat |
| Gut inflammation | Oral, IP injection | Inflammation markers, tissue histology | Rat, mouse |
What Has Not Been Tested in Humans
The Translation Gap
None of the mechanisms described above have been confirmed in a controlled human trial. We know that BPC-157 activates certain pathways in rat cells and tissues. We do not know whether the same activation occurs in human tissues at similar concentrations. Dose scaling between a 250-gram rat and a 70-kilogram human is not straightforward for peptides: metabolism, distribution and clearance all differ. The gap between animal pharmacology and human pharmacology is where most drug candidates fail, and BPC-157 has not crossed it yet.
FAQ, How BPC-157 Works
Does BPC-157 work through one pathway or many?
The publication proposes different pathways that include nitric oxide, regulation of growth factors, angiogenesis and FAK-paxillin. It is still unclear if these pathways are independent or interrelated, and this still ponders in the literature.
Has BPC-157 been studied in human cells?
To date, only a few short in-vitro studies have involved human cell lines to research BPC-157 action. This type of study involves cell cultures but not clinical trials on humans. Consequently, while such studies do provide some information about the mechanism of action of the compound, they cannot denote what would happen to BPC-157 in the human body.
How long do effects last in animal models?
Duration of studies varies. In most acute injury models, effects are observed for days to weeks after administration. There is a lack of long term follow up information. The animal literature does not provide sufficient information for the duration of effect, tolerance, or the long term safety.
Is the mechanism of BPC-157 fully understood?
Not really. The proposed mechanism is dependent on correlations noted in animal studies. In order to attain mechanistic insight confirmation is needed across species including but not limited to studying dose-response and identifying the primary receptor or binding site of importance.
Compare the current picks
Prices, sizes and ratings side by side, updated when the merchant pages change.
See top picks